Skip to main content

Analysts Have Conflicting Sentiments on These Communication Services Companies: Reddit Inc Class A (RDDT) and Roblox (RBLX)

Tipranks - Sat Feb 7, 5:54AM CST

Companies in the Communication Services sector have received a lot of coverage today as analysts weigh in on Reddit Inc Class A (RDDTResearch Report) and Roblox (RBLXResearch Report).

Claim 50% Off TipRanks Premium

Reddit Inc Class A (RDDT)

In a report released today, Brian Nowak from Morgan Stanley maintained a Buy rating on Reddit Inc Class A, with a price target of $240.00. The company’s shares closed last Thursday at $151.05.

According to TipRanks.com, Nowak is a 5-star analyst with an average return of 8.1% and a 60.0% success rate. Nowak covers the NA sector, focusing on stocks such as Alphabet Class A, Meta Platforms, and Pinterest. ;'>

Reddit Inc Class A has an analyst consensus of Moderate Buy, with a price target consensus of $261.59, representing a 73.2% upside. In a report issued on January 23, Guggenheim also maintained a Buy rating on the stock with a $245.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

Roblox (RBLX)

In a report released today, Doug Creutz from TD Cowen maintained a Sell rating on Roblox, with a price target of $70.00. The company’s shares closed last Thursday at $60.57.

According to TipRanks.com, Creutz is a 5-star analyst with an average return of 14.9% and a 62.1% success rate. Creutz covers the NA sector, focusing on stocks such as Live Nation Entertainment, Starz Entertainment Corp, and Paramount Skydance. ;'>

Currently, the analyst consensus on Roblox is a Moderate Buy with an average price target of $115.63.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.